仙乐健康 （300791.SZ）
27.59 +0.33（1.210%）
+ 收藏
今开：27.49 最高：27.65 成交量：1.01万手
昨收：27.26 最低：26.80 成交额：2769.82万
利润表（仙乐健康）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 3,048,456,382.86 | 1,990,478,159.06 | 951,504,195.36 | 3,582,022,297.17 | 2,502,922,802.68 | 1,544,847,837.25 | 702,158,705.58 |
| 营业收入(元) | 3,048,456,382.86 | 1,990,478,159.06 | 951,504,195.36 | 3,582,022,297.17 | 2,502,922,802.68 | 1,544,847,837.25 | 702,158,705.58 |
| 二、营业总成本(元) | 2,813,726,698.28 | 1,825,237,477.96 | 879,047,243.89 | 3,311,572,714.55 | 2,305,834,727.33 | 1,444,525,424.24 | 683,269,157.07 |
| 营业成本(元) | 2,097,116,584.96 | 1,352,624,855.78 | 660,171,232.59 | 2,497,911,669.03 | 1,748,274,556.78 | 1,089,856,315.50 | 507,878,014.52 |
| 研发费用(元) | 98,626,917.14 | 67,292,784.29 | 30,794,385.11 | 110,494,627.39 | 75,471,289.32 | 46,496,020.83 | 22,478,475.33 |
| 营业税金及附加(元) | 22,130,544.42 | 13,306,653.45 | 6,943,324.96 | 22,414,702.98 | 15,957,547.11 | 9,451,541.02 | 4,583,866.33 |
| 销售费用(元) | 232,824,240.44 | 155,861,144.70 | 73,086,246.12 | 277,608,277.49 | 185,346,698.10 | 114,345,161.14 | 52,297,298.08 |
| 管理费用(元) | 296,966,131.63 | 197,654,990.16 | 91,971,266.66 | 350,830,160.17 | 245,462,851.88 | 165,414,017.62 | 83,050,186.67 |
| 财务费用(元) | 66,062,279.69 | 38,497,049.58 | 16,080,788.45 | 52,313,277.49 | 35,321,784.14 | 18,962,368.13 | 12,201,209.93 |
| 其中：利息费用(元) | 73,391,053.58 | 45,955,037.29 | 17,797,747.50 | 61,856,078.25 | 50,001,367.73 | 32,023,686.22 | 11,564,701.01 |
| 其中：利息收入(元) | 4,860,999.75 | 3,401,695.29 | 1,398,682.44 | 7,016,136.93 | 8,762,653.19 | 3,261,766.03 | 1,791,638.10 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | 4,287,826.08 | 2,617,963.04 | 2,741,910.99 | -57,671,784.35 | -12,816,293.78 | -6,978,164.34 | 800,273.96 |
| 加：投资收益(元) | -3,750,850.99 | -3,753,294.76 | -4,869,171.98 | 2,219,562.72 | 3,981,765.21 | 2,688,543.93 | 994,849.33 |
| 资产处置收益(元) | 131,961.11 | 131,961.11 | 131,961.11 | 34,010.25 | 22,900.05 | 47,109.17 | - |
| 资产减值损失(元) | -2,232,420.61 | -2,025,127.14 | -1,362,568.92 | 405,379.29 | -828,294.24 | -2,242,170.86 | -397,782.86 |
| 信用减值损失(元) | 146,180.30 | 1,160,332.25 | 69,468.21 | -5,177,105.91 | -451,130.78 | 2,421,536.20 | 1,699,011.21 |
| 其他收益(元) | 13,617,786.78 | 9,441,099.39 | 3,745,697.18 | 71,765,029.85 | 10,562,398.72 | 6,679,847.43 | 2,979,330.10 |
| 四、营业利润(元) | 246,930,167.25 | 172,813,614.99 | 72,914,248.06 | 282,024,674.47 | 197,559,420.53 | 102,939,114.54 | 24,965,230.25 |
| 加：营业外收入(元) | 1,819,514.20 | 1,701,948.74 | 1,153,300.77 | 1,364,680.09 | 1,285,430.95 | 536,648.63 | 244,593.61 |
| 减：营业外支出(元) | 6,799,573.60 | 6,329,938.44 | 4,743,215.32 | 10,132,526.70 | 2,111,441.04 | 727,865.85 | 286,102.48 |
| 五、利润总额(元) | 241,950,107.85 | 168,185,625.29 | 69,324,333.51 | 273,256,827.86 | 196,733,410.44 | 102,747,897.32 | 24,923,721.38 |
| 减：所得税费用(元) | 29,224,869.86 | 32,270,370.80 | 15,453,196.98 | 32,969,032.59 | 37,032,497.02 | 22,803,586.87 | 6,165,404.20 |
| 六、净利润(元) | 212,725,237.99 | 135,915,254.49 | 53,871,136.53 | 240,287,795.27 | 159,700,913.42 | 79,944,310.45 | 18,758,317.18 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 212,725,237.99 | 135,915,254.49 | 53,871,136.53 | 240,287,795.27 | 159,700,913.42 | 79,944,310.45 | 18,758,317.18 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 239,801,624.33 | 154,473,292.80 | 63,029,722.56 | 281,038,527.77 | 185,147,820.63 | 101,185,645.67 | 29,399,867.21 |
| 少数股东损益(元) | -27,076,386.34 | -18,558,038.31 | -9,158,586.03 | -40,750,732.50 | -25,446,907.21 | -21,241,335.22 | -10,641,550.03 |
| 扣除非经常性损益后的净利润(元) | 236,355,111.39 | 154,467,443.83 | 64,930,448.59 | 280,827,314.10 | 184,500,943.51 | 99,346,277.92 | 25,455,628.46 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 1.34 | 0.86 | 0.35 | 1.56 | 1.03 | 0.56 | 0.16 |
| 二、稀释每股收益(元) | 1.34 | 0.86 | 0.35 | 1.56 | 1.03 | 0.56 | 0.19 |
| 八、其他综合收益(元) | -9,191,308.79 | -12,520,525.85 | -26,692,941.41 | 19,667,233.37 | 73,625,275.16 | 76,347,618.77 | -129,634,097.86 |
| 归属于母公司股东的其他综合收益(元) | -7,376,817.45 | -13,250,682.71 | -21,136,400.31 | 14,237,409.72 | 70,485,395.12 | 74,560,549.63 | -102,206,070.76 |
| 归属于少数股东的其他综合收益(元) | -1,814,491.34 | 730,156.86 | -5,556,541.10 | 5,429,823.65 | 3,139,880.04 | 1,787,069.14 | -27,428,027.10 |
| 九、综合收益总额(元) | 203,533,929.20 | 123,394,728.64 | 27,178,195.12 | 259,955,028.64 | 233,326,188.58 | 156,291,929.22 | -110,875,780.68 |
| 归属于母公司所有者的综合收益总额(元) | 232,424,806.88 | 141,222,610.09 | 41,893,322.25 | 295,275,937.49 | 255,633,215.75 | 175,746,195.30 | -72,806,203.55 |
| 归属于少数股东的综合收益总额(元) | -28,890,877.68 | -17,827,881.45 | -14,715,127.13 | -35,320,908.85 | -22,307,027.17 | -19,454,266.08 | -38,069,577.13 |
| 公告日期 | 2024-10-24 | 2024-08-12 | 2024-04-22 | 2024-04-22 | 2023-10-26 | 2023-08-25 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 归属于少数股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries